![Benjamin Beneski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 423 883 $ au 31/05/2026
Benjamin M.
Beneski currently works at Allogene Therapeutics, Inc., as Chief Technical Officer & Senior Vice President from 2025.
Mr. Beneski received his undergraduate degree from Stevens Institute of Technology and Masters Business Admin degree from Northeastern University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 195 338 ( 0,06% ) | 423 883 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 28/02/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Stevens Institute of Technology
 Stevens Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
